Dexamethasone and dextran 40 treatment of 32 patients with severe acute pancreatitis
Authors:
- Zi-Fa WangZWZi-Fa Wang
- Chang LiuCLChang Liu
- Yi LuYLYi Lu
- Rui DongRDRui Dong
- Jun XuJXJun Xu
- Liang YuLYLiang Yu
- Ying-Min YaoYYYing-Min Yao
- Qing-Guang LiuQLQing-Guang Liu
- Cheng-En PanCPCheng-En Pan
Open Access
- 1 January 2004
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 10 (9) , 1333-1336
Abstract
AIM: Based on the pathogenesis of severe acute pancreatitis and our experimental studies, to investigate the effect of dexamethasone and dextran in treatment of patients with severe acute pancreatitis. METHODS: Thirty-two patients with severe acute pancreatitis were treated with 0.5-1 mg/kg per day dexamethasone for 3-5 d, and 500-1 000 mL/d of dextran 40 for 7 d, besides the routine therapy. RESULTS: After 4-8 h of treatment, abdominal pain began to be relieved; range of tenderness began to be localized in 27 patients. They were cured with nonsurgical treatment. Five of them were deteriorated, and treated with surgery. Four patients in this group died. CONCLUSION: Dexamethasone and dextran 40 block the pathologic process of severe acute pancreatitis through inhibition of inflammatory mediators and improvement of microcirculation disorders respectively.Keywords
This publication has 52 references indexed in Scilit:
- The effect of steroid pulse therapy on the development of acute pancreatitis induced by closed duodenal loop in ratsJournal of Gastroenterology, 2002
- Prevention of severe change in acute pancreatitis: prediction and preventionJournal of Hepato-Biliary-Pancreatic Surgery, 2001
- Optimising Outcomes in Acute PancreatitisDrugs, 2001
- Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitisGut, 2001
- A monoclonal anti-interleukin 8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotising pancreatitis in rabbitsGut, 1998
- Experimental study of a novel phospholipase A2 inhibitor in acute pancreatitisBritish Journal of Surgery, 1998
- Benefits of various dextrans after delayed therapy in necrotizing pancreatitis of the ratIntensive Care Medicine, 1996
- Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitisBritish Journal of Surgery, 1995
- Decreased Mortality of Severe Acute Pancreatitis After Proximal Cytokine BlockadeAnnals of Surgery, 1995
- Isovolemic Hemodilution with Dextran 60 as Treatment of Pancreatic Ischemia in Acute Pancreatitis Clinical Practicability of an Experimental ConceptAnnals of Surgery, 1993